| 000 | 01912 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516041843.0 | ||
| 264 | 0 | _c20111102 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1432-0851 | ||
| 024 | 7 |
_a10.1007/s00262-011-1049-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLang, Joshua M | |
| 245 | 0 | 0 |
_aPilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cOct 2011 |
||
| 300 |
_a1447-60 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xtherapy |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xtherapy |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell, gamma-delta _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aKaikobad, Mahazarin R | |
| 700 | 1 | _aWallace, Marianne | |
| 700 | 1 | _aStaab, Mary Jane | |
| 700 | 1 | _aHorvath, Dorothea L | |
| 700 | 1 | _aWilding, George | |
| 700 | 1 | _aLiu, Glenn | |
| 700 | 1 | _aEickhoff, Jens C | |
| 700 | 1 | _aMcNeel, Douglas G | |
| 700 | 1 | _aMalkovsky, Miroslav | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 60 _gno. 10 _gp. 1447-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-011-1049-8 _zAvailable from publisher's website |
| 999 |
_c20905797 _d20905797 |
||